Echo(cardiography) in a first-line and second-line approach

被引：0
|
作者：
Garretsen, JW [1 ]
机构：
[1] Specialist Dierenklin, Vet Specialist Ctr De Wagenrenk, Utrecht, Netherlands
来源：
TIJDSCHRIFT VOOR DIERGENEESKUNDE | 1998年 / 123卷 / 20期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：592 / 593
页数：2
相关论文
共 50 条
  • [41] SECOND-LINE TREATMENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER PROGRESSED AFTER FIRST-LINE FOLFOXIRI
    Fornaro, Lorenzo
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Salvatore, Lisa
    Stasi, Irene
    Baldi, Giacomo Giulio
    Cupini, Samanta
    Barbara, Cecilia
    Pfanner, Elisabetta
    Brunetti, Isa Maura
    Di Donato, Samantha
    Caponi, Sara
    Allegrini, Giacomo
    Antonuzzo, Andrea
    Ricci, Sergio
    Chiara, Silvana
    Vitello, Stefano
    Andreuccetti, Michele
    Falcone, Alfredo
    ANNALS OF ONCOLOGY, 2009, 20
  • [42] Resistance in Pediatric Patients Experiencing Virologic Failure With First-line and Second-line Antiretroviral Therapy
    Orrell, Catherine
    Levison, Julie
    Ciaranello, Andrea
    Bekker, Linda-Gail
    Kuritzkes, Daniel R.
    Freedberg, Kenneth A.
    Wood, Robin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) : 644 - 647
  • [43] Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon
    Njom-Nlend, Anne-Esther
    Efouba, Nadege
    Brunelle Sandie, Arsene
    Fokam, Joseph
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 (08) : 927 - 935
  • [44] Failure of Vedolizumab as First-Line Biologic Does Not Decrease Response Rates of Second-Line Therapy
    Ritter, Timothy E.
    Fourment, Chris
    Okoro, Tracy C.
    Hardin, Thomas C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S381 - S382
  • [45] Why SMART about second-line treatment when first-line treatment is being ignored?
    Nelson, Harold S.
    Dorinsky, Paul M.
    CHEST, 2006, 130 (03) : 929 - 929
  • [46] Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
    Sun, Maxine
    Larcher, Alessandro
    Karakiewicz, Pierre I.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2014, 7 : 401 - 407
  • [47] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
  • [48] Second-line treatments in patients with metastatic colorectal cancer progressed after first-line FOLFOXIRI
    Masi, G.
    Vasile, E.
    Loupakis, F.
    Fornaro, L.
    Salvatore, L.
    Cupini, S.
    Stasi, I.
    Brunetti, I. M.
    Andreuccetti, M.
    Falcone, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 346 - 347
  • [49] Impact of first-line treatment response on second-line therapy with nintedanib plus docetaxel in advanced lung adenocarcinoma after combined first-line immunochemotherapy
    Grohe, C.
    Wehler, T.
    Henschke, S.
    Dittrich, I
    Hammerschmidt, S.
    Aulmann, C.
    Dechow, T.
    Schiefer, C.
    von der Heyde, E.
    Schuette, W.
    Atz, J.
    Kaiser, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 208 - 208
  • [50] Comparative analysis of profiles of second-line stage IV renal cell carcinoma patients by first-line to second-line treatment sequencing in the United States.
    DaSilva, Corrina
    Spindel, Julie
    Franceschetti, Alessandra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345